In vivo imaging of invasive aspergillosis with 18 F-fluorodeoxysorbitol positron emission tomography.
Dong-Yeon KimAyoung PyoSehyeon JiSung-Hwan YouSeong Eun KimDaejin LimHeejung KimKyung-Hwa LeeSe-Jeong OhYe-Rim JungUh Jin KimSubin JeonSeong Young KwonSae-Ryung KangHyang-Burm LeeHoon HyunSo-Young KimKyung-Sub MoonSunwoo LeeSeung Ji KangJung-Joon MinPublished in: Nature communications (2022)
Invasive aspergillosis is a critical complication in immunocompromised patients with hematologic malignancies or with viral pneumonia caused by influenza virus or SARS‑CoV‑2. Although early and accurate diagnosis of invasive aspergillosis can maximize clinical outcomes, current diagnostic methods are time-consuming and poorly sensitive. Here, we assess the ability of 2-deoxy-2- 18 F-fluorosorbitol ( 18 F-FDS) positron emission tomography (PET) to specifically and noninvasively detect Aspergillus infections. We show that 18 F-FDS PET can be used to visualize Aspergillus fumigatus infection of the lungs, brain, and muscles in mouse models. In particular, 18 F-FDS can distinguish pulmonary aspergillosis from Staphylococcus aureus infection, both of which induce pulmonary infiltrates in immunocompromised patients. Thus, our results indicate that the combination of 18 F-FDS PET and appropriate clinical information may be useful in the differential diagnosis and localization of invasive aspergillosis.
Keyphrases
- positron emission tomography
- computed tomography
- sars cov
- pet ct
- pet imaging
- staphylococcus aureus
- end stage renal disease
- pulmonary hypertension
- high resolution
- mouse model
- ejection fraction
- chronic kidney disease
- respiratory failure
- prognostic factors
- respiratory syndrome coronavirus
- healthcare
- peritoneal dialysis
- multiple sclerosis
- escherichia coli
- resting state
- patient reported outcomes
- brain injury
- coronavirus disease
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- cell wall